Epigenetic clocks read DNA methylation at thousands of sites
Epigenetic clocks are mathematical models built from methylated DNA marks. They turn it into a quantified biological age from accessible samples. This estimate differs from chronological age in some individuals. It aims to reflect processes linked to aging rather than elapsed time alone. These tools emerged from large-scale association studies.
These clocks measure methylation signatures distributed across the genome. Each model uses a subset of CpG sites selected statistically. These sites are not all linked to aging genes. Interpretation must remain cautious about their biological meaning. The link between score and causal mechanism is not established for all models. That distinction matters to avoid clinical overinterpretation.
The interest lies in the difference between epigenetic age and chronological age. This gap is sometimes called accelerated age. It has been associated with certain risk factors in observational studies. These associations do not prove a causal effect. Use in practice must remain cautious and contextualized. It must take into account the methodological limits of the model used.
| Measurement | Principle | Documented use | Main limit |
|---|---|---|---|
| Horvath clock (2013) | DNA methylation on a selected set of loci | Estimation of calendar age in research | Calibrated on age, little information on health status |
| Second-generation clocks | Methylation residual after removing age | Ranking groups within the same age range | Small differences and counterintuitive interpretation |
| DunedinPACE (2022) | Decline slope of more than 1,000 clinical measures over 20 years | Measurement of the pace of aging and comparison of interventions | Instrumental variability of several points |
| Commercial biological age kits | DNA methylation on a subset of sites, depending on the kit | Educational and motivational use | Neither validated nor reproducible from one kit to another |
| Classic clinical indicators | Direct measurements: blood pressure, glucose, function | Medical decision and follow-up | Sensitive to the measurement context |
What each biological age measurement allows and does not allow
Biological age reads as a reflection of a trajectory, not as an individual verdict
Several clocks exist with different goals. Some predict chronological age. Others aim to predict mortality or disease risk. These differences explain results that vary between studies. The choice of model must be justified by the question asked.
The estimated biological age reflects statistical correlates, not a single mechanism. Factors such as smoking, obesity or certain treatments can be associated with it. These associations are often moderate and vary between populations. They do not allow a conclusion of direct causality. Interpretation must remain descriptive and nuanced.
Reproducibility depends on laboratory and analysis methods. Technical variations can influence results. Comparing scores obtained with different protocols is difficult. This heterogeneity limits the generalization of interpretation thresholds. The absence of standardized reference values complicates clinical use.

DunedinPACE estimates the pace of aging rather than an isolated age
The potential usefulness concerns research and certain exploratory contexts. These tools can help study factors linked to aging at population level. They do not replace standard clinical assessment. The classic workup remains the foundation of medical decisions. Their added value must be demonstrated in each context of use.
Studies show associations with events, but with variable strength. Predictive accuracy differs depending on the outcome considered. For a given individual, the margin of uncertainty is often large. That uncertainty limits application to precise individual decisions. An isolated gap should not be overinterpreted. The trend across several measurements is more informative than a single value.
In practice, explaining this to the patient must stay clear and honest. What the epigenetic clock measures, and what it does not, must be stated. The emphasis should be on known modifiable factors rather than on the score alone. This approach avoids false reassurance or unjustified worry.

Consumer anti-aging tests remain outside any prescription framework
The main limits concern the lack of standardization between models. There is no universally validated threshold for clinical interpretation. Studies are mostly observational. These factors complicate extrapolation to all contexts.
The functional meaning of the CpG sites used remains partial. Many are not directly involved in aging processes. The score reflects a statistical signal rather than a precise physiological state. That distinction limits mechanistic inferences.
Accessibility and cost do not guarantee clinical relevance. A test must demonstrate decisive added value before being integrated into practice. At present, the evidence is insufficient for routine use. That limit justifies a cautious approach in any clinical use.

DNA methylation varies with the tissue sampled and the platform used
Interpretation must take place within the person's overall context. Chronological age, comorbidities and lifestyle provide more decision elements. An isolated epigenetic gap is not enough to change management. This approach limits the risk of overestimating results.
Communicating results requires particular vigilance. Aging must not be embodied in a single number. Language must stay nuanced, stating the uncertainties. Explaining what the test does not allow is as important as explaining what it does.
Knowledge in this field is evolving fast. Current models will probably be improved in the future. That dynamic justifies regularly reassessing their clinical relevance. The professional favors solid scientific evidence.

Structuring the consultation when someone arrives with an epigenetic clock result
In summary, epigenetic clocks are statistical tools useful in research. Their direct clinical usefulness remains limited to date. They must not replace clinical assessment or established markers. Cautious, contextualized interpretation is essential.
The key point is to distinguish association from causality. This principle guides the interpretation of these emerging biomarkers. It avoids hasty conclusions while staying open to advances. Scientific nuance must take precedence over technological enthusiasm.
In the future, methodological improvements could clarify their role. For now, the most honest approach is to acknowledge their limits as much as their interest. Epigenetic clocks bring hypotheses, not certainties. That precision limits the risk of mistaken interpretation.

Sources
- 1.Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013.
- 2.Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022.
- 3.Belsky DW, et al. Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing? Am J Epidemiol. 2018.
- 4.Bell CG, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019.
- 5.Biomarkers of Aging Consortium. Challenges and recommendations for the translation of biomarkers of aging. Nat Aging. 2024.
- 6.Oblak L, et al. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res Rev. 2021.
- 7.Fitzgerald KN, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging (Albany NY). 2021.
Reading studies is one thing, turning them into a plan is another
The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.
11 modules, €2,200. Enrol
Continue reading
Benjamin Sant
Co-founder of the School of Longevity
Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.
This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.
